Thale Dawn Patrick-Brown
- Clinical Trial Manager; MSc, MIET
Thale has a varied background, and joined OUH after working in public sector research environments in the UK, Norway and Canada. She holds degrees from the University of Reading (MSc) and the University of Lethbridge (BSc), and is a PhD Student at Heriot-Watt University in Edinburgh, Scotland.
Thale's main research focus is currently epidemiology and pandemic response under the SARS CoV-2 pandemic.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
Ann Surg Oncol, 28 (1), 252-257
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
Clin Transl Radiat Oncol, 21, 5-10